Articles

• Cutting the costs of patient compliance

  Dr Mike Sokol, corporate medical director for Merck and Co., on how value-based benefit design can boost adherence.

  (Dec 1, 2009)
• Strategic approaches to emerging markets

  Three forecasting and marketing experts on the opportunities and challenges of emerging markets

  (Jan 19, 2010)
• Market access in the EU: Navigating regulation

  How to tailor forecasts to the unique characteristics of individual markets.

  (Jan 19, 2010)
• Making e-marketing effective

  Aaron Uydess, senior e-marketing manager at Novo Nordisk, on how to align Web 2.0 strategies to business goals.

  (Jan 26, 2010)
• The pharmacist as an ally in patient adherence

  Stacey Irving, director of channel marketing at McKesson, on how pharmacists can help increase compliance.

  (Feb 9, 2010)
• To Tweet or not to Tweet? That is the pharma marketers question

  John Pugh, corporate communications director at Boehringer Ingelheim, on why pharma should be taking Twitter more seriously.

  (Feb 23, 2010)
• The upside of social media in marketing

  Geir Ove Harnes, senior communications manager, MSD Norway, on why you should be on FaceBook

  (Feb 23, 2010)
• Key factors for market access

  Ed Schoonfeld of ZS Associates offers tips for market access success, from scenario analysis to risk sharing.

  (Feb 25, 2010)
• The US Healthcare System and Patient Compliance

  Richard Montwill, VP market strategy at Optum Health, on how improved adherence in the US can reduce waste and inefficiency.

  (Mar 9, 2010)
• Patient Compliance and Specialty Pharmacy Products

  Kevin Cast, VP of CuraScript, on how adherence can boost cost-effectiveness and improve forecasting.

  (Mar 9, 2010)
• 1
• 2
• 3
• Next
• Last

History

Member for

2 years 10 weeks